通过结构化报告(BT-RADS)实现脑肿瘤MRI的定量改进
该研究分析BT-RADS实施前后胶质瘤治疗后报告的可量化指标,发现实施后病史词更常被记录、模糊词使用减少、报告更简洁、补遗更少,提示报告一致性与完整性提高。
要点
- BT-RADS实施后报告更常记录临床病史词(如Avastin、MGMT),减少模糊措辞。
- 实施后报告总字数与印象部分字数均减少,补遗比例降低。
- 结构化报告可提升胶质瘤治疗后MRI报告的一致性与完整性。
核心结论
- 实施BT-RADS后,胶质瘤报告在临床病史方面更一致完整,模糊性减少,更简洁。
研究设计与样本
- 经机构审查委员会批准,从BT-RADS实施前后两个匹配的3个月时间段获取治疗后胶质瘤报告,分析病史词、模糊词、总字数、印象部分字数及是否含补遗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Determine the objective benefits of structured reporting of brain tumors through Brain tumor-RADS (BT-RADS) by analyzing discrete quantifiable metrics of the reports themselves.
MATERIALS AND METHODS: Following Institutional Review Board approval, post-treatment glioma reports were acquired from two matched 3-month time periods for pre- and postimplementation of BT-RADS. The reports were analyzed for presence of history words, such as "Avastin" and "methylguanine-DNA methyltransferase," as well as hedge words, such as "Possibly" and "Likely." The word counts of the total report and of the impression section were also assessed, as well as whether or not the report contained addenda.
RESULTS: In total, 211 pre-BT-RADS and 172 post-BT-RADS reports were analyzed. Post-BT-RADS reports demonstrated greater reporting of history words, including "Avastin" (7.6% vs. 20.9%, p < 0.001) and "methylguanine-DNA methyltransferase" (10.9% vs. 31.4%, p < 0.0001). They also demonstrated reduced usage of hedge words, including "Possibly" (3.8% vs. 0.6%, p < 0.05) and "Likely" (49.8% vs. 28.5%, p < 0.01). Furthermore, post-BT-RADS reports possessed fewer words in total report length (389 vs. 245.2, p < 0.001), as well as in the impression section (53.7 vs. 42.6, p < 0.01). Finally, fewer post-BT-RADS reports contained addenda (10% vs. 1.2%, p < 0.01).
CONCLUSION: Following implementation of BT-RADS, glioma reports demonstrated greater consistency and completeness of clinical history, less ambiguity, and more conciseness.
引用
- Zhang JY, Weinberg BD, Hu R, et al. Quantitative Improvement in Brain Tumor MRI Through Structured Reporting (BT-RADS). Acad Radiol. 2019. PMID: 31471207. doi:10.1016/j.acra.2019.07.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。